Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.50 |
| ▸ | PSEN2 | P49810 | 3/20 | 0.50 |
| ▸ | APH1B | Q8WW43 | 3/20 | 0.50 |
| ▸ | NCSTN | Q92542 | 3/20 | 0.50 |
| ▸ | APH1A | Q96BI3 | 3/20 | 0.50 |
| ▸ | PSENEN | Q9NZ42 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 2/20 | 0.39 |
| ▸ | ELANE | P08246 | 2/20 | 0.39 |
| ▸ | CTSG | P08311 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6377395 | 1.00 | USP2 (0.56) | USP2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL5704537 | 0.89 | USP2 (0.67) | USP2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL7317628 | 0.89 | USP2 (0.67) | USP2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL18452704 | 0.85 | USP2 (0.48) | USP2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL6378716 | 0.82 | USP2 (0.62) | USP2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL6378723 | 0.82 | USP2 (0.62) | USP2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL25760699 | 0.82 | USP2 (0.43) | USP2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL18476696 | 0.82 | USP2 (0.43) | USP2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL345968 | 0.81 | USP2 (0.69) | USP2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL9006395 | 0.81 | USP2 (0.65) | USP2PSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050245432-A1 | N-methyl amino acids | UBIQUITOUS TECHNOLOGIES PTY. LTD. (AU) | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245432-A1 | N-methyl amino acids | VIP, NPPA, PTMS | USP2 1849/4885PSEN1 565/4885PSEN2 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.